About Advances in Pulmonary Hypertension
Publisher
Matt J. Granato, LL.M., MBA, President & CEO
[email protected]
PHA Office
Pulmonary Hypertension Association
8401 Colesville Road, Suite 200
Silver Spring, MD 20910
301-565-3004; 301-565-3994 (fax)
Publishing Operations
Tori Cortez, Managing Editor
KnowledgeWorks Global Ltd.
[email protected]
General Information
Advances in Pulmonary Hypertension: Official Journal of the Pulmonary Hypertension Association (PHA) is a quarterly publication directed by an editorial board of renowned pulmonary hypertension (PH) experts with oversight by PHA's Scientific Leadership Council. Its mission is to assist physicians in their clinical decision-making by informing them of important trends affecting their practice and providing an analysis of the impact of new findings in peer-reviewed publications. Issue themes are independently selected by the Editorial Board after an analysis of newly released data and practice gaps. A guest editor invites thought leaders in the selected topic area to author reviews of these timely subject. Each article is finally reviewed and approved by members of the Editorial Board.
Objectives
- Provide up-to-date information regarding epidemiology, pathophysiology, diagnosis, and treatment of pulmonary hypertension (PH).
- Serve as a forum for presentation and discussion of important issues in the field, including new paradigms of disease understanding and investigational trial design.
- Recognize and preserve the rich history of individuals who have made major contributions to the field via dedication to patient care, innovative research, and furthering the mission of the PH community to cure pulmonary hypertension.